Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1259970.RALEvHVY_aiwAd4n3UAFQdHOKBMHT-5mQJHzvikKwPTmA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1259970.RALEvHVY_aiwAd4n3UAFQdHOKBMHT-5mQJHzvikKwPTmA130_assertion type Assertion NP1259970.RALEvHVY_aiwAd4n3UAFQdHOKBMHT-5mQJHzvikKwPTmA130_head.
- NP1259970.RALEvHVY_aiwAd4n3UAFQdHOKBMHT-5mQJHzvikKwPTmA130_assertion description "[ABCC1 and ABCC4 are thus potential targets for therapeutic suppression in high-risk neuroblastoma, and recently developed small-molecule inhibitors may be an effective strategy in treating aggressive forms of this cancer, as well as other cancers that express high levels of these transporters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259970.RALEvHVY_aiwAd4n3UAFQdHOKBMHT-5mQJHzvikKwPTmA130_provenance.
- NP1259970.RALEvHVY_aiwAd4n3UAFQdHOKBMHT-5mQJHzvikKwPTmA130_assertion evidence source_evidence_literature NP1259970.RALEvHVY_aiwAd4n3UAFQdHOKBMHT-5mQJHzvikKwPTmA130_provenance.
- NP1259970.RALEvHVY_aiwAd4n3UAFQdHOKBMHT-5mQJHzvikKwPTmA130_assertion SIO_000772 25640269 NP1259970.RALEvHVY_aiwAd4n3UAFQdHOKBMHT-5mQJHzvikKwPTmA130_provenance.
- NP1259970.RALEvHVY_aiwAd4n3UAFQdHOKBMHT-5mQJHzvikKwPTmA130_assertion wasDerivedFrom befree-2016 NP1259970.RALEvHVY_aiwAd4n3UAFQdHOKBMHT-5mQJHzvikKwPTmA130_provenance.
- NP1259970.RALEvHVY_aiwAd4n3UAFQdHOKBMHT-5mQJHzvikKwPTmA130_assertion wasGeneratedBy ECO_0000203 NP1259970.RALEvHVY_aiwAd4n3UAFQdHOKBMHT-5mQJHzvikKwPTmA130_provenance.